Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options-Reference-Cited by-同舟云学术

Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options

Published:2022-12-28 Issue:48 Volume:28 Page:6827-6845
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:World J Gastroenterol

Author:

Zhang Chun-Ye,Liu Shuai,Yang Ming

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference165 articles.

1. American Cancer Society. Key Statistics for Pancreatic Cancer. 2022. [cited 3 November 2022]. Available from: https://www.cancer.org/cancer/pancreatic-cancer/about/key-statistics.html

2. Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer

3. The global burden of pancreatic cancer

4. Diagnostic biomarkers for pancreatic cancer: An update

5. Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming therapy resistance in pancreatic cancer: New insights and future directions;Biochemical Pharmacology;2024-11

2. EREG silencing inhibits tumorigenesis via inactivating ERK/p38 MAPK pathway in pancreatic ductal adenocarcinoma;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. Traditional Biomarkers in Patients with Pancreatic Cancer Staged by Computed Tomography and Endoscopic Ultrasound: Is There Still a Role in the Molecular Era?;Gastrointestinal Disorders;2024-08-07

4. DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family;Discover Oncology;2024-08-03

5. Metastatic Pancreatic Cancer Now in Remission: A Case Report and Literature Review;2024-08-01